| Literature DB >> 11763155 |
Abstract
Interleukin (IL)-2 is known to play a key role in the pathophysiology of psoriasis by activating T-cells. In recent years, therapies have been developed to specifically prevent T-cell activation by blocking the production of IL-2 or by inhibiting its action. These new therapies are discussed.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11763155
Source DB: PubMed Journal: Curr Opin Investig Drugs ISSN： 1472-4472